Additionally, we found that deletion of NEAT1 accelerated AML progression in multiple murine AML models, mediated by MLL‐AF9, HOXA9‐Meis1, or FLT3‐ITD. The gene discussed is FLT3; the disease is acute myeloid leukemia.